Innoviva (INVA) Return on Sales Growth (3y) (2014 - 2026)
Innoviva (INVA) Return on Sales Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn | 1.00 |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 1.00 |
| 10 | Innoviva | 1.61 Bn | 1.00 Bn | 75.83 Mn | -17.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.00 |
| Dec 31, 2025 | -1.00 |
| Sep 30, 2025 | -1.00 |
| Jun 30, 2025 | -5.00 |
| Mar 31, 2025 | -18.00 |
| Dec 31, 2024 | 33.00 |
| Sep 30, 2024 | -1.00 |
| Jun 30, 2024 | -41.00 |
| Mar 31, 2024 | -55.00 |
| Dec 31, 2023 | -384.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -1.00 |
| Mar 31, 2023 | 18.00 |
| Dec 31, 2022 | -16.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 4.00 |
| Mar 31, 2022 | 16.00 |
| Dec 31, 2021 | -49.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 40.00 |